| NHC | National Health Council; neighborhood health center; neonatal hypocalcemia; nonhistone chromosomal [... |
|---|---|
| NHCP | nonhistone chromosomal protein |
| RMSCR | rhabdomyosarcoma chromosomal region |
| WAGR syndrome | Wilms's Tumor Aniridia Genital Anomalies Me... |
| ICF | immunodeficiency-centromeric instability-facial anomalies [syndrome]; indirect centrifugal flotation... |
| newborn screening | Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism. (12 Dec 1998) |
|---|---|
| Denver Developmental Screening Test | A scale used by psychologists and paediatricians to assess the developmental, intellectual, motor, and social maturity of children at any age level from birth to adolescence. (05 Mar 2000) |
| differential screening | Process in development of a multicellular organism by which cells become specialised for particular functions. Requires that there is selective expression of portions of the genome, the fully differentiated state may be preceded by a stage in which the cell is already programmed for differentiation but is not yet expressing the characteristic phenotype determination. (18 Nov 1997) |
| drug screening | Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. (12 Dec 1998) |
| drug screening assays, antitumour | Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumour growth parameters in laboratory animals. (12 Dec 1998) |
| familial screening | Screening directed at close relatives of probands with diseases that may lie latent, as in age-dependent dominant traits, or that may involve risk to progeny, as X-linked traits. (05 Mar 2000) |